Clinical Trials in Colorado

Showing 981-1000 of 15,592 trials

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

NCT06660290

The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).

Dry Eye Disease

Alcon Research55 participantsStarted Jan 2025

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Andover, Massachusetts, United States +3 more locations

Active Not RecruitingPhase 350 miles

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

NCT00379340

This phase III trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with newly diagnosed stage III or stage IV Wilms' tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving more than one drug (combination chemotherapy) with or without radiation therapy may kill more tumor cells.

Stage III Kidney Wilms TumorStage IV Kidney Wilms Tumor

Children's Oncology Group395 participantsStarted Apr 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +224 more locations

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Find Trials by Condition in Colorado

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

Study of VYD2311 for the Prevention of COVID-19

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV